Based in San Antonio, Texas, Rochal Industries LLC., a global leader in commercializing technology innovations in natural and synthetic polymers, antimicrobials, and biological systems, announced that Dr. Rebecca McMahon has been named President of the company. Ann Beal Salamone, Rochal’s past-President and Co-Founder has been elected as Chairman of the Board. Ron Nixon, the previous Chairman of the Board and the Founder and Managing Partner of the Catalyst group, will step down as Chairman but remain on the Board of Directors.
FORT WORTH, TX / ACCESSWIRE / October 16, 2019 / Sanara MedTech Inc. (OTCQB:SMTI). Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara”), a provider of surgical and chronic wound care products dedicated to improving patient outcomes, announced today that it has closed a private placement offering of 1,204,820 shares of its common stock at a price of $8.30 per share. All shares are being sold by Sanara as newly issued shares.
Based in Fort Worth, Texas, Sanara MedTech Inc. (Sanara), a provider of surgical and chronic wound care products dedicated to improving patient outcomes, announced today the execution of an exclusive worldwide licensing agreement with Rochal Industries, LLC, to market, sell, distribute, and further develop two new impactful products: BIAKŌS™ Antimicrobial Barrier Film and No Sting Skin Protectant. Both products are FDA cleared and are expected to launch in the first quarter of 2020.
The Napa Valley resort was named the No. 10 best hotel in the nation in U.S. News' annual list. Auberge du Soleil was recognized for its beautiful scenery, on-site offerings, arranged activities, and gourmet food.
FORT WORTH, TX / ACCESSWIRE / August 29, 2019 / Sanara MedTech Inc. (OTCQB:SMTI).
Based in Fort Worth, Texas, Sanara MedTech Inc. (SMTI), a provider of surgical and chronic wound care products dedicated to improving patient outcomes, announced today the election of Dr. Kenneth Thorpe and Ms. Ann Beal Salamone to Sanara’s Board of Directors.
The Family Alignment LLC investment partnership will be managed by The Catalyst Group founder and president Ron Nixon, along with principals Brad Gurasich, David McWhorter and Robert Norris.
FORT WORTH, TX / ACCESSWIRE / June 7, 2019 / Sanara MedTech Inc. (OTCQB: SMTI) announced today that the Financial Industry Regulatory Authority (FINRA) has approved the Company’s request to change its stock ticker symbol from WNDMD to SMTI effective at the start of trading on June 7, 2019. The stock will be traded under a the CUSIP number 79957L100.
June 1, 2019 | 8:00 AM CDT
High velocity natural gas pipelines pose a unique challenge in terms of effective cleaning for corrosion mitigation purposes or pre ILI runs. Studies show that the best cleaning occurs when the tool runs at approximately 8 mph ( 3.57 m/s) allowing brushes and discs to do their job, where at speeds over 10 mph (4.47 m/s) they can bypass the debris and liquids, proving ineffective.
LAFAYETTE, La., Dec. 15, 2016 (GLOBE NEWSWIRE) -- YPS Anesthesia Services, a provider of outsourced anesthesia care in Louisiana, Mississippi and Texas, announced today that it has received an investment from The Catalyst Group, Inc. (“Catalyst”) through their Family Alignment partnership. Tracy Young, founder and CEO of YPS, along with partner and CFO John Mendell and the existing management team, will continue to lead the business in its expansion plans.
A biomedical engineering professor's research on treatment options for optical nerve trauma, particularly for injured soldiers, leads to collaboration with Rochal to develop new material that can deliver doses of therapeutic drugs to injured nerves.